Cargando…

Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments

The diagnosis of neurodegenerative diseases (NDDs) represents an increasing social burden, with the unsolved issue of disease-modifying therapies (DMTs). The failure of clinical trials treating Alzheimer′s Disease (AD) so far highlighted the need for a different approach in drug design and patient s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giampietri, Linda, Belli, Elisabetta, Beatino, Maria Francesca, Giannoni, Sara, Palermo, Giovanni, Campese, Nicole, Tognoni, Gloria, Siciliano, Gabriele, Ceravolo, Roberto, De Luca, Ciro, Baldacci, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029739/ https://www.ncbi.nlm.nih.gov/pubmed/35453843 http://dx.doi.org/10.3390/diagnostics12040796

Ejemplares similares

Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
por: Del Prete, Eleonora, et al.
Publicado: (2020)

Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals
por: Stoccoro, Andrea, et al.
Publicado: (2022)

Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review
por: Palermo, Giovanni, et al.
Publicado: (2021)

Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity
por: Elefante, Camilla, et al.
Publicado: (2023)

Confabulations in Cases of Dementia: Atypical Early Sign of Alzheimer’s Disease or Misleading Feature in Dementia Diagnosis?
por: Belli, Elisabetta, et al.
Publicado: (2020)

Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022)

Mitochondrial ANT-1 related adPEO leading to cognitive impairment: is there a link?
por: Simoncini, Costanza, et al.
Publicado: (2017)

The Epidemiology and Clinical Manifestations of Dysexecutive Syndrome in Parkinson’s Disease
por: Ceravolo, Roberto, et al.
Publicado: (2012)

Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia
por: Galgani, Alessandro, et al.
Publicado: (2022)

Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease
por: De Luca, Ciro, et al.
Publicado: (2021)

Biomarker-guided classification scheme of neurodegenerative diseases
por: Baldacci, Filippo, et al.
Publicado: (2016)

The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders
por: Paraskevas, George P.
Publicado: (2022)

Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay
por: Cammisuli, Davide Maria, et al.
Publicado: (2021)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

Dissecting Migraine: The Future of Anatomical, Functional, and Liquid Biomarkers
por: De Luca, Ciro, et al.
Publicado: (2022)

Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine
por: Dini, Elisa, et al.
Publicado: (2019)

P041. Analysis of body mass index, psychiatric comorbidity, sleep-wake pattern and occurrence of fatigue in episodic and chronic migraine patients
por: Lucchesi, Cinzia, et al.
Publicado: (2015)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
por: Daniele, Simona, et al.
Publicado: (2018)

The Microbiota/Microbiome and the Gut–Brain Axis: How Much Do They Matter in Psychiatry?
por: Marazziti, Donatella, et al.
Publicado: (2021)

Correction: Marazziti et al. The Microbiota/Microbiome and the Gut–Brain Axis: How Much Do They Matter in Psychiatry? Life 2021, 11, 760
por: Marazziti, Donatella, et al.
Publicado: (2022)

Association between Cerebrospinal Fluid Soluble TREM2, Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Zhou, Wenchuan, et al.
Publicado: (2023)

Ageing and Neurodegenerative Disorders
por: Piccardi, Laura, et al.
Publicado: (2015)

Superconfinement tailors fluid flow at microscales
por: Setu, Siti Aminah, et al.
Publicado: (2015)

A Pilot Study Evaluating the Contribution of SLC19A1 (RFC-1) 80G>A Polymorphism to Alzheimer's Disease in Italian Caucasians
por: Coppedè, Fabio, et al.
Publicado: (2014)

Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes
por: Piccarducci, Rebecca, et al.
Publicado: (2019)

Molecular Imaging of the Dopamine Transporter
por: Palermo, Giovanni, et al.
Publicado: (2019)

Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-C
por: Bellini, Gabriele, et al.
Publicado: (2021)

Could Temperamental Features Modulate Participation in Clinical Trials?
por: Cintoli, Simona, et al.
Publicado: (2023)

Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study
por: Baldanzi, Sigrid, et al.
Publicado: (2016)

Cerebrospinal fluid sampling for research of Alzheimer’s disease and other neurodegenerative diseases when lumbar punctures are performed by anaesthetists
por: Atkins, Kelly J, et al.
Publicado: (2022)

Social Cognition and Oxytocin in Huntington’s Disease: New Insights
por: Unti, Elisa, et al.
Publicado: (2018)

Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006)

Chronic traumatic encephalopathy and other neurodegenerative proteinopathies
por: Tartaglia, Maria Carmela, et al.
Publicado: (2014)

Lactobacillus rhamnosus BMX 54 + Lactose, A Symbiotic Long-Lasting Vaginal Approach to Improve Women’s Health
por: Baldacci, Filippo, et al.
Publicado: (2020)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
por: Wakamatsu, Keiji, et al.
Publicado: (2022)

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2020)

Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature
por: Di Carlo, Davide Tiziano, et al.
Publicado: (2020)

Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases
por: Rohan, Zdenek, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8jg4jtmk0ifq5vl140kd7l3cag